Pricing
  1. US-listed companies
  2. BIOLASE, INC
  3. Financials
  4. Free cash flow

BIOLASE, INC【BIOLQ】

Market cap
$36.6
P/E ratio
SummaryFinancials
Period EndFree cash flow (Million USD)YoY (%)
Dec 31, 2023-15-49.52%
Dec 31, 2022-31+75.27%
Dec 31, 2021-17+35.11%
Dec 31, 2020-13-0.48%
Dec 31, 2019-13-11.91%
Dec 31, 2018-15-23.25%
Dec 31, 2017-19+58.85%
Dec 31, 2016-12-38.39%
Dec 31, 2015-20+19.37%
Dec 31, 2014-16+64.47%
Dec 31, 2013-10+303.36%
Dec 31, 2012-2-82.02%
Dec 31, 2011-14

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)